Litigation Details for Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)
✉ Email this page to a colleague
Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-11-12 |
| Court | District Court, D. Massachusetts | Date Terminated | 2021-02-04 |
| Cause | 28:1338 Patent Infringement | Assigned To | Allison Dale Burroughs |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,469,012; 8,183,002; 9,200,002 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc.
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-12-03 | 243 | Proposed Findings of Fact | the prior art discloses overlapping ranges. Tr. 8-183:2-11; MPEP § 2144.05 (“In the case where the claimed… Term ’956 patent U.S. Patent No. 8,961,956 ’321 patent … U.S. Patent No. 8,962,321 ’551 patent U.S. Patent No. 9,745,551 ACT…the ’551 patent would apply equally to the continuation patent Defendants filed, U.S. Patent No. 10,557,122… Astellas’ ’956 patent (or the ’551 patent) by suggesting | External link to document |
| 2020-12-03 | 244 | Proposed Findings of Fact | use for a pre-existing compound. See U.S. Patent No. 6,469,012. The compound had been known for years in…basis for the patent applications that later become the ‘321 patent and the ‘956 patent.19 See TX-48;…the ‘551 patent, that they be added to the ‘321 patent, Dr. Wang be added to the ’956 patent, and that… unjust enrichment.”). 4 U.S. Patent No. 8,961,956. 5 U.S. Patent No. 8,962,321. …), which would later mature into the ‘321 Patent, and Patent Cooperation Treaty Application No. PCT/US2012 | External link to document |
| 2020-12-15 | 247 | Exhibit Redline of Defendants' Corrected FOF COL | use for a pre-existing compound. See U.S. Patent No. 6,469,012. The compound had been known for years in…basis for the patent applications that later become the ‘321 patent and the ‘956 patent.19 See TX-48;…the ‘551 patent, that they be added to the ‘321 patent, Dr. Wang be added to the ’956 patent, and that… unjust enrichment.”). 4 U.S. Patent No. 8,961,956. 5 U.S. Patent No. 8,962,321. …), which would later mature into the ‘321 Patent, and Patent Cooperation Treaty Application No. PCT/US2012 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
